Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anna Morisco
Observed names:
A. Morisco,
MORISCO, Anna,
Morisco Anna,
Morisco, Anna
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institutions:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
Centro Interuniversitario di Ricerca sui Peptidi Bioattivi,
University of Naples Federico II
OpenAlex ID:
A5006427609
Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent
2012
·
Giancarlo Morelli
, Antonella Accardo
, et al.
·
International Journal of Nanomedicine
·
71
PDF
Micelles derivatized with octreotide as potential target‐selective contrast agents in MRI
2008
·
Anna Morisco
, Antonella Accardo
, et al.
·
Journal of Peptide Science
·
44
Peptide modified nanocarriers for selective targeting of bombesin receptors
2010
·
Antonella Accardo
, Rosalba Mansi
, et al.
·
Molecular BioSystems
·
42
Bombesin peptide antagonist for target-selective delivery of liposomal doxorubicin on cancer cells
2012
·
Antonella Accardo
, Rosalba Mansi
, et al.
·
Journal of drug targeting
·
39
Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma
2014
·
Luigi Aloj
, Laura D’Ambrosio
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
38
Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor (GRP-R) ligands for in vivo targeting of receptor-expressing tumors
2016
·
Antonella Accardo
, Filippo Galli
, et al.
·
EJNMMI Research
·
31
PDF
Nanoparticles containing octreotide peptides and gadolinium complexes for MRI applications
2010
·
Antonella Accardo
, Anna Morisco
, et al.
·
Journal of Peptide Science
·
30
Analysis of Pros and Cons in Using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007: Production, Costs, and PET/CT Applications in Patients with Prostate Cancer
2022
·
Costantina Maisto
, Michela Aurilio
, et al.
·
Molecules
·
29
PDF
A comparison of simplified protocols of personalized dosimetry in NEN patients treated by radioligand therapy (RLT) with [177Lu]Lu-DOTATATE to favor its use in clinical practice
2023
·
Valentina Pirozzi Palmese
, Laura D’Ambrosio
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
18
PDF
Amphiphilic CCKpeptides assembled in supramolecular aggregates: structural investigations and in vitro studies
2010
·
Antonella Accardo
, Anna Morisco
, et al.
·
Molecular BioSystems
·
18
Peptide‐labeled supramolecular aggregates as selective doxorubicin carriers for delivery to tumor cells
2010
·
Anna Morisco
, Antonella Accardo
, et al.
·
Biopolymers
·
18
On site production of [18F]PSMA-1007 using different [18F]fluoride activities: practical, technical and economical impact
2021
·
Costantina Maisto
, Anna Morisco
, et al.
·
EJNMMI Radiopharmacy and Chemistry
·
17
PDF
Naposomes: a New Class of peptide-derivatized, target-selective Multimodal Nanoparticles for Imaging and Therapeutic Applications
2011
·
Antonella Accardo
, Anna Morisco
, et al.
·
Therapeutic Delivery
·
12
Micelles obtained by aggregation of gemini surfactants containing the CCK8 peptide and a gadolinium complex
2009
·
Antonella Accardo
, Diego Tesauro
, et al.
·
JBIC Journal of Biological Inorganic Chemistry
·
8
[225Ac]Ac-PSMA-617 production method: development of an efficient and reproducible radiolabelling process for establish a clinical routine production
2025
·
Michela Aurilio
, Aureliana Esposito
, et al.
·
EJNMMI Radiopharmacy and Chemistry
·
5
PDF
[177Lu] Lu-PSMA-I&T for prostate cancer radioligand therapy: A radiopharmacy’s journey from synthesis to cost-effectiveness
2026
·
Michela Aurilio
, Costantina Maisto
, et al.
·
Applied Radiation and Isotopes
Dosimetric comparison between 177LU-PSMA-617 and 177LU-PSMA I&T in patients with metastatic castration resistant prostate cancer (MCRPC) using a ring-shaped CZT-based camera
2026
·
L. D’Ambrosio
, F. Manna
, et al.
·
Physica Medica
RETRACTED: [177Lu] Lu-PSMA-I&T for Prostate Cancer Radioligand Therapy: A Radiopharmacy's Journey from Synthesis to Cost-Effectiveness
2025
·
Michela Aurilio
, Costantina Maisto
, et al.
·
Research Square
Dosimetry in Patients Treated With Lutetium-177 Labelled Peptides: the Int G. Pascale Experience
2023
·
V. Pirozzi Palmese
, L. D’Ambrosio
, et al.
·
Physica Medica
Comparison of [68Ga]Ga-PSMA-11, [18F]PSMA1007 and [177Lu]Lu-PSMA-617 in detecting the same prostate cancer lesions. The evidences from the clinical practice in a dedicated Cancer Institution.
2023
·
de Marino, Roberta
, Morisco, Anna
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Analysis of Pros and Cons in using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007: production, costs and PET/CT applications in patients with Prostate Cancer.
2022
·
Maisto Costantina
, Aurilio Michela
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Clinical practice implementation of personalized dosimetry in patients treated with 177Lu-DOTATATE
2021
·
V. Pirozzi Palmese
, L. D’Ambrosio
, et al.
·
Physica Medica
Role of Positron Emission Tomography/Computed Tomography
2015
·
Secondo Lastoria
, Luigi Aloj
, et al.
·
Updates in surgery/Updates in surgery series
Prognostic value of interim PET in aggressive non Hodgkin lymphoma
2015
·
Luigi Aloj
, Ferdinando Frigeri
, et al.
·
Journal of Nuclear Medicine
111In and 68Ga labelled GluDTPA and DOTA-gastrin analogs: A biological and functional analysis
2010
·
Diego Tesauro
, Anna Lucia Tornesello
, et al.
Show more works
View as search
Works count:
27
Citation count:
420
H-index:
12
I10-index:
13
Year
Topic
Type